Anna Mowry's most recent trade in Nautilus Biotechnology Inc was a trade of 160,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nautilus biotech Inc | Anna Mowry | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus biotech Inc | Anna Mowry | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 0.77 per share. | 29 May 2025 | 15,000 | 83,000 | - | 0.8 | 11,489 | Common Stock |
| Nautilus biotech Inc | Anna Mowry | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus biotech Inc | Anna Mowry | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus biotech Inc | Anna Mowry | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus biotech Inc | Anna Mowry | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 2.30 per share. | 19 Aug 2022 | 17,500 | 56,750 | - | 2.3 | 40,219 | Common Stock |
| Nautilus biotech Inc | Anna Mowry | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 27 Jun 2022 | 5,500 | 39,250 | - | 2.7 | 15,124 | Common Stock |
| Nautilus biotech Inc | Anna Mowry | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 4.58 per share. | 24 Nov 2021 | 15,000 | 32,500 | - | 4.6 | 68,633 | Common Stock |
| Nautilus biotech Inc | Anna Mowry | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 7.71 per share. | 12 Aug 2021 | 17,500 | 17,500 | - | 7.7 | 134,925 | Common Stock |